We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$133B
1-Year Est. Return
43.5%
This Fund
S&P 500
This Quarter
Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
(+13%)
Cap. Flow
-$1.75B
Cap. Flow
% of AUM
-1.32%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$117M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$117M |
| 3 |
SPCX
SpaceX
SPCX
|
+$100M |
| 4 |
P
Everpure Inc
P
|
+$67.3M |
| 5 |
Roku
ROKU
|
+$53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$212M |
| 2 |
Microsoft
MSFT
|
+$156M |
| 3 |
Amazon
AMZN
|
+$142M |
| 4 |
Honeywell
HON
|
+$119M |
| 5 |
NVIDIA
NVDA
|
+$94.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.1% |
| 2 | Financials | 11.93% |
| 3 | Industrials | 10.35% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Healthcare | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Enovis
ENOV
$1.06B
| $3.07M | ﹤0.01% |
148,408
-18,452
| -11% | -$435K |
|
|
DHC
1702
Diversified Healthcare Trust
DHC
$1.97B
| $3.07M | ﹤0.01% |
329,836
+22,623
| +7% | +$185K |
|
|
PRSU
1703
Pursuit Attractions and Hospitality Inc
PRSU
$1.34B
| $3.06M | ﹤0.01% |
54,750
-11,593
| -17% | -$512K |
|
1704
Skyward Specialty Insurance
SKWD
$2.43B
| $3.06M | ﹤0.01% |
52,400
+5,667
| +12% | +$267K |
|
1705
Sonic Automotive
SAH
$2.05B
| $3.04M | ﹤0.01% |
35,885
-8,891
| -20% | -$683K |
|
1706
1st Source
SRCE
$2.07B
| $3.04M | ﹤0.01% |
37,274
+715
| +2% | +$53.4K |
|
1707
J&J Snack Foods
JJSF
$1.45B
| $3.03M | ﹤0.01% |
41,317
-3,450
| -8% | -$269K |
|
1708
FuelCell Energy
FCEL
$1.32B
| $3.03M | ﹤0.01% |
84,127
+70,357
| +511% | +$1.14M |
|
1709
BJ's Restaurants
BJRI
$1.28B
| $3.03M | ﹤0.01% |
49,868
-9,905
| -17% | -$433K |
|
1710
Gorman-Rupp
GRC
$1.96B
| $3.02M | ﹤0.01% |
32,949
+223
| +0.7% | +$16.9K |
|
1711
Innodata
INOD
$2.38B
| $3.02M | ﹤0.01% |
39,922
+2,141
| +6% | +$157K |
|
1712
Nektar Therapeutics
NKTR
$1.95B
| $3.01M | ﹤0.01% |
43,094
+42,494
| +7,082% | +$3.11M |
|
1713
Axogen
AXGN
$2.55B
| $3.01M | ﹤0.01% |
65,068
+8,628
| +15% | +$348K |
|
|
DEA
1714
Easterly Government Properties
DEA
$1.08B
| $3M | ﹤0.01% |
120,516
-10,867
| -8% | -$255K |
|
|
JBS
1715
JBS N.V.
JBS
$38.1B
| $3M | ﹤0.01% |
253,284
+230,699
| +1,021% | +$3.37M |
|
1716
Select Water Solutions
WTTR
$2.56B
| $3M | ﹤0.01% |
150,019
+19,535
| +15% | +$342K |
|
1717
Heritage Financial
HFWA
$1.17B
| $3M | ﹤0.01% |
101,132
-5,260
| -5% | -$145K |
|
1718
SGHC Ltd
SGHC
$6.08B
| $2.99M | ﹤0.01% |
220,967
+17,689
| +9% | +$224K |
|
1719
Intellia Therapeutics
NTLA
$1.65B
| $2.99M | ﹤0.01% |
176,725
+40,137
| +29% | +$562K |
|
1720
Nurix Therapeutics
NRIX
$2.39B
| $2.99M | ﹤0.01% |
123,072
-295
| -0.2% | -$5.03K |
|
1721
Redwire
RDW
$2.9B
| $2.96M | ﹤0.01% |
241,916
+117,269
| +94% | +$1.55M |
|
1722
V2X
VVX
$2.37B
| $2.96M | ﹤0.01% |
39,681
+5,838
| +17% | +$434K |
|
1723
Agios Pharmaceuticals
AGIO
$1.95B
| $2.95M | ﹤0.01% |
79,441
+6,072
| +8% | +$184K |
|
|
AVNS
1724
DELISTED
Avanos Medical
AVNS
| $2.94M | ﹤0.01% |
118,317
-19,065
| -14% | -$446K |
|
|
FIG
1725
Figma
FIG
$11.1B
| $2.94M | ﹤0.01% |
162,351
+158,051
| +3,676% | +$3.18M |
|
Similar funds
RhumbLine Advisers's Q2 2026 Portfolio in Review
As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 182 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.
- RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
- RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
- RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
- RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
- RhumbLine Advisers opened 224 new positions and closed 182 in Q2 2026.
- RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.